Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

NOBELSPEEDY Shorty RP 4: medical device reports filed with FDA

2,108 reports name it, 2019–2026. Manufacturer given most often on reports: Nobel Biocare. Product code DZE.

2,108
device reports naming the brand
0% of all MAUDE reports · about 309 a year
220
reports, 12 months to August 2026
228 in the 12 months before
1.3%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 2,108 reports that name the brand "NOBELSPEEDY Shorty RP 4" (endosseous dental implant), received between September 2019 and August 2026; the manufacturer given most often on reports is Nobel Biocare. Spellings of one product vary from report to report.

220 reports arrived in the 12 months to August 2026, close to the 228 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (98.7%) and malfunction (1.3%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are loss of osseointegration (56.7%), failure to osseointegrate (31.1%) and osseointegration problem (7.4%). The patient problems coded most often are failure of implant, pain and numbness. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

03672Sep 2021: 30Oct 2021: 26Nov 2021: 32Dec 2021: 362022Jan 2022: 38Feb 2022: 26Mar 2022: 32Apr 2022: 46May 2022: 42Jun 2022: 54Jul 2022: 30Aug 2022: 30Sep 2022: 24Oct 2022: 20Nov 2022: 28Dec 2022: 282023Jan 2023: 22Feb 2023: 10Mar 2023: 24Apr 2023: 6May 2023: 20Jun 2023: 30Jul 2023: 29Aug 2023: 21Sep 2023: 18Oct 2023: 14Nov 2023: 56Dec 2023: 182024Jan 2024: 22Feb 2024: 72Mar 2024: 32Apr 2024: 18May 2024: 16Jun 2024: 32Jul 2024: 14Aug 2024: 18Sep 2024: 12Oct 2024: 22Nov 2024: 6Dec 2024: 262025Jan 2025: 12Feb 2025: 24Mar 2025: 20Apr 2025: 2May 2025: 0Jun 2025: 0Jul 2025: 48Aug 2025: 56Sep 2025: 12Oct 2025: 20Nov 2025: 34Dec 2025: 182026Jan 2026: 22Feb 2026: 18Mar 2026: 14Apr 2026: 18May 2026: 8Jun 2026: 22Jul 2026: 32Aug 2026: 2

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01993982019: 15120192020: 28820202021: 33120212022: 39820222023: 26820232024: 29020242025: 24620252026: 1362026

Event type and report source

Event type, as classified on the report

Death0%0
Injury98.7%2,081
Malfunction1.3%27
Other0%0
Not given0%0

Who filed the report

Manufacturer report52.8%1,113
Voluntary report0%0
User facility report0%0
Distributor report47.2%995
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Loss of osseointegration1,19656.7%22.4%
Failure to osseointegrate65531.1%62.8%
Osseointegration problem1577.4%7.7%
Fracturea broken bone120.6%1.6%
Patient device interaction problem60.3%0.3%
Premature separation60.3%0.1%
Activation, positioning or separation problem20.1%0%
Device damaged by another device20.1%0%
Device markings/labelling problema problem with the device markings or label20.1%0%
Difficult to insertthe device was hard to insert20.1%0.4%
Insufficient device problem information20.1%0.2%
Material deformation20.1%0.1%
Mechanical problema mechanical problem20.1%0.1%
Migrationthe device moved from where it was placed20.1%0.1%
Separation failure20.1%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant1,77284.1%
Painpain, site not specified42120%
Numbnessnumbness894.2%
Appropriate clinical signs, symptoms and conditions term/code not available422%
Inflammationinflammation401.9%
Abscessa collection of pus120.6%
Bone fracture(s)20.1%
Fistula20.1%
Foreign body in patientpart of a device left in the patient20.1%
Implant pain20.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureNOBELSPEEDY Shorty RP 4Product code DZEAll MAUDE reports
Reports2,1083,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury98.7%99.2%36.2%
Classified as malfunction1.3%0.8%62.3%
Filed by the manufacturer52.8%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about NOBELSPEEDY Shorty RP 4 reports

How many FDA reports name NOBELSPEEDY Shorty RP 4?

2,108 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 220 in the latest 12 months.

What kinds of events are reported?

injury (98.7%) and malfunction (1.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

loss of osseointegration (56.7%), failure to osseointegrate (31.1%), osseointegration problem (7.4%), fracture (0.6%) and patient device interaction problem (0.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (52.8%) and distributor reports (47.2%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that NOBELSPEEDY Shorty RP 4 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.